Foamix Pharmaceuticals
www.foamix.comFoamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.
Read more
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.
Read more
Country
City (Headquarters)
Reẖovot
Industry
Founded
2003
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Owner
Email ****** @****.comPhone (***) ****-****Director
Email ****** @****.comPhone (***) ****-****Senior Director , Clinical Operations
Email ****** @****.comPhone (***) ****-****Regional Sales Manager - Northeast
Email ****** @****.comPhone (***) ****-****
Technologies
(24)
